# A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer

> **NCT05068024** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Forward Pharmaceuticals Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** FWD1509 MsOH

## Key facts

- **NCT ID:** NCT05068024
- **Lead sponsor:** Forward Pharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-23
- **Primary completion:** 2022-10-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05068024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05068024, "A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05068024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*